Circulation, Vol 74, 530-543, Copyright © 1986 by American Heart Association
OM Hess, T Murakami and HP Krayenbuehl
A beneficial effect of verapamil on left ventricular relaxation has been
reported in patients with hypertrophic cardiomyopathy. The effect of 0.1
mg/kg intravenous verapamil on left ventricular relaxation and diastolic
mechanics was studied in 10 patients with hypertrophic cardiomyopathy and
13 patients with aortic stenosis. M mode echocardiograms and left
ventricular high-fidelity pressure measurements were obtained
simultaneously in patients at rest and 10 to 15 min after verapamil. The
time constant of left ventricular pressure decay (T; in msec) and the
pressure intercept (PB; in mm Hg) were calculated from left ventricular
pressure and negative dP/dt during isovolumetric relaxation with the use of
a linear regression analysis. Left ventricular early and mean diastolic
filling rates as well as diastolic pressure-diameter relationships before
and after verapamil were determined from simultaneous echocardiographic and
pressure measurements. After verapamil heart rate, left ventricular peak
systolic pressure, and maximum and minimum dP/dt remained unchanged in both
groups. Left ventricular end-diastolic pressure increased significantly
from 15 to 17 mm Hg (p less than .02) in patients with aortic stenosis but
did not change in those with hypertrophic cardiomyopathy. However, the time
constant T decreased significantly from 79 to 60 msec (p less than .001) in
patients with hypertrophic cardiomyopathy but increased significantly from
53 to 68 msec (p less than .025) in those with aortic stenosis. Parallel to
the decrease in time constant, early (5.3 vs 7.3 cm/sec, p less than .05)
and mean (3.0 vs 4.3 cm/sec, p less than .06) diastolic lengthening rate
increased in patients with hypertrophic cardiomyopathy after verapamil. In
contrast, early (7.7 vs 7.6 cm/sec, p = NS) and mean (4.3 vs 4.2 cm/sec, p
= NS) diastolic lengthening rate remained unchanged in patients with aortic
stenosis. The diastolic pressure-diameter relationship did not change in
either group after verapamil. Cycle efficiency of the left ventricular
pressure-diameter loop was significantly decreased in patients with
hypertrophic cardiomyopathy when compared with that in those with aortic
stenosis (71% vs 80%; p less than .01), but improved significantly from 71%
to 77% (p less than .02) in patients with hypertrophic cardiomyopathy and
remained unchanged in those with aortic stenosis (80% vs 80%) after
verapamil. We conclude that verapamil improves left ventricular relaxation
in patients with hypertrophic cardiomyopathy but delays relaxation in those
with aortic stenosis.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?
This article has been cited by other articles:
![]() |
M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF] |
||||
![]() |
M. Jorg-Ciopor, M. Namdar, J. Turina, R. Jenni, J. Schwitter, M. Turina, O. M. Hess, and P. A. Kaufmann Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 163 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF] |
||||
![]() |
A. Hartmann, J. Schnell, R. Hopf, and G. Kneissl Persisting Effect of Ca2+-Channel Blockers on Left Ventricular Function in Hypertrophic Cardiomyopathy After 14 Years' Treatment Angiology, August 1, 1996; 47(8): 765 - 773. [Abstract] [PDF] |
||||
![]() |
P. H. Pak, W. L. Maughan, K. L. Baughman, and D. A. Kass Marked Discordance Between Dynamic and Passive Diastolic Pressure-Volume Relations in Idiopathic Hypertrophic Cardiomyopathy Circulation, July 1, 1996; 94(1): 52 - 60. [Abstract] [Full Text] |
||||
![]() |
K. M. Kessler Heart Failure With Normal Systolic Function: Update of Prevalence, Differential Diagnosis, Prognosis, and Therapy Arch Intern Med, October 1, 1988; 148(10): 2109 - 2111. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |